Skip to content
Screener

EBITDA at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$9.1B+5.9%
Stryker logo
StrykerSYK
$1.24B+11.5%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$14.44M+0.2%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$3.45M+85.9%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$8.39M-38.5%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$18.9M+56.7%
Gross profit$14.5M+64.0%
Operating income-$11.0M-69.7%
Net income-$10.5M-55.3%
EPS (diluted)-$0.39+73.5%

Balance sheet

See full
Cash & equivalents$46.2M+38.2%
Total debt$21.9M+23.8%
Total equity$84.2M+201%
Total assets$118.2M+122%

Cash flow

See full
Operating cash flow-$7.4M-4.5%
CapEx$121.0K-63.0%
Free cash flow-$7.5M-1.5%

Valuation

See full
Market cap$377.32M+11.1%
Enterprise value$353M
P/S

Profitability

See full
Gross margin76.6%+2.6pp
Operating margin-61.1%-3.1pp
Net margin-57.4%-6.2pp
FCF margin-54.6%-10.6pp

Returns & leverage

See full
Return on equity-6,196.9%
Debt / equity0.3×
Current ratio8.8×+4.0×

Where this comes from

Calculated from Carlsmed, Inc.’s reported figures.

$11.0Mebit+
$130.0KDepreciation Depletion & Amortization
=-$10.91M

The source filing: Carlsmed, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:10 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001794546-26-000016

FAQ

What is Carlsmed, Inc.'s EBITDA?
Carlsmed, Inc. (CARL) reported EBITDA of -$10.91M in Q2 2026.
How has Carlsmed, Inc.'s EBITDA changed year-over-year?
Carlsmed, Inc.'s EBITDA decreased by 69.3% year-over-year, from -$6.44M to -$10.91M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about Carlsmed, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude